阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AZN 阿斯利康

交易中 08-17 15:08:15 EDT

156.10

-0.35

-0.23%

最高157.26	最低155.78	成交量230.45万
今开156.22	昨收156.45	日振幅0.95%
总市值2,421亿	流通市值2,340亿	总股本15.51亿
成交额3.61亿	换手率0.15%	流通股本14.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"阿斯利康","latestPrice":156.095,"timestamp":1786993691490,"preClose":156.45,"halted":0,"volume":2304536,"delay":0,"changeRate":-0.0022690955576860966,"floatShares":1498932637,"shares":1551000000,"eps":6.679974,"marketStatus":"交易中","change":-0.355,"latestTime":"08-17 15:08:15 EDT","open":156.22,"high":157.26,"low":155.78,"amount":360585401.39648,"amplitude":0.00946,"askPrice":156.11,"askSize":210,"bidPrice":156.08,"bidSize":2,"shortable":3,"etf":0,"ttmEps":6.679974,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786996800000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NYSE","adjPreClose":156.45,"dividendRate":0.020693,"preHourTrading":{"tag":"盘前","latestPrice":156.31,"preClose":156.45,"latestTime":"09:29 EDT","volume":34223,"amount":5365232.1121,"timestamp":1786973399149,"change":-0.14,"changeRate":-0.000895,"amplitude":0.008949},"postHourTrading":{"tag":"盘后","latestPrice":156.0249,"preClose":156.45,"latestTime":"19:58 EDT","volume":35279,"amount":5519296.9453,"timestamp":1786751936806,"change":-0.4251,"changeRate":-0.002717,"amplitude":0.002717},"volumeRatio":0.739025,"impliedVol":0.277,"impliedVolPercentile":0.4143},"requestUrl":"/m/hq/s/AZN/wiki","defaultTab":"wiki","newsList":[{"id":"2660248062","title":"阿斯利康(AZN.US)/第一三共ADC一线治疗肺癌III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248062","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660248062?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:44","pubTimestamp":1786970699,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月17日，阿斯利康和第一三共联合宣布Enhertu单药一线治疗非小细胞肺癌的III期DESTINY-Lung04研究取得了高水平的积极结果。结果显示，Enhertu组患者的PFS较标准治疗组实现了统计学显著且临床意义显著的改善。值得一提的是，Enhertu是第一个在III期研究中成功证明单药相较标准治疗作为一线治疗方案能够改善NSCLC患者的PFS的ADC药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1267930573.SGD","LU2456880835.USD","AZNH","BK4231","LU0029864427.USD","LU0128525929.USD","ADC","LU2237443622.USD","LU0058720904.USD","LU1829250122.USD","BK4585","BK4007","LU0109394709.USD","LU0708994859.HKD","NETL","LU0289739699.SGD","BK4588","LU2462157665.USD","LU0320765992.SGD","LU2237443382.USD","LU0432979614.USD","BK4134","IE00B3T34201.USD","LU2236285917.USD","BK4080","LU0310800379.SGD","LU2237443549.SGD","III","LU2237443465.HKD","LU2417539215.USD","BK4568","LU2468319806.SGD","LU0889565916.HKD","LU2237443895.HKD","LU2237443978.SGD","LU2089984988.USD","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660147484","title":"阿斯利康终止一项肺癌三期临床试验，称疗效难达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2660147484","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660147484?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:11","pubTimestamp":1786965064,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","LU0708994859.HKD","LU2236285917.USD","BK4007","LU2456880835.USD","LU0029864427.USD","LU1829250122.USD","LU0432979614.USD","LU1267930573.SGD","PSYK","LU2237443382.USD","BK4588","LU0310800379.SGD","LU2089984988.USD","AZN","LU0109394709.USD","LU2462157665.USD","AZNH","LU0889565916.HKD","LU2237443622.USD","BMED","LU2237443465.HKD","LU2468319806.SGD","LU2237443549.SGD","LU2237443895.HKD","LU0128525929.USD","BK4568","MDTX","IBBJ","LU0289739699.SGD","BK4585","IE00B3T34201.USD","LU0320765992.SGD","LU2417539215.USD","LU2237443978.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660485253","title":"阿斯利康（AZN）再遇重大临床研发挫折 宣布停止肺癌治疗药物Volrustomig三期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2660485253","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660485253?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:52","pubTimestamp":1786956744,"startTime":"0","endTime":"0","summary":"研究结果显示，与现有的标准治疗方案相比，Volrustomig联合化疗未能显著提升晚期肺癌患者的生存率。值得注意的是，这也是阿斯利康在过去一个月内遭遇的第二次重大临床研发挫折。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303852","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2237443549.SGD","IE00B3T34201.USD","BK4007","LU0128525929.USD","LU0058720904.USD","LU2089984988.USD","LU0109394709.USD","LU2236285917.USD","LU2237443622.USD","LU2468319806.SGD","LU2237443465.HKD","LU2237443895.HKD","AZNH","LU0289739699.SGD","LU1267930573.SGD","LU2456880835.USD","LU0432979614.USD","LU2417539215.USD","LU0310800379.SGD","AZN","LU2237443978.SGD","LU0889565916.HKD","BK4568","LU2462157665.USD","LU0320765992.SGD","BK4588","LU1829250122.USD","LU2237443382.USD","LU0029864427.USD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660362485","title":"阿斯利康（AZN）与日本第一三共联合宣布重磅抗体偶联药物Enhertu®三期临床取得重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2660362485","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660362485?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:41","pubTimestamp":1786956109,"startTime":"0","endTime":"0","summary":"金吾财讯 | 跨国制药巨头阿斯利康 与日本第一三共联合宣布，其合作开发的重磅抗体偶联药物Enhertu在代号为“DESTINY-Lung04”的全球三期临床试验中取得积极成果。这是全球首个且唯一在HER2突变型非小细胞肺癌一线治疗中战胜标准疗法的HER2靶向药物。据悉，HER2突变型非小细胞肺癌约占非小细胞肺癌患者的2%至4%，常见于较年轻且无吸烟史的女性患者，侵袭性强且易发生脑转移。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4588","BK4585","LU2417539215.USD","BK4007","BK4568","LU2237443622.USD","LU0432979614.USD","AZNH","LU2237443549.SGD","LU0128525929.USD","LU0708994859.HKD","LU2089984988.USD","LU2468319806.SGD","LU0289739699.SGD","LU2237443978.SGD","LU2237443895.HKD","IE00B3T34201.USD","LU2237443465.HKD","LU0109394709.USD","LU2462157665.USD","LU0320765992.SGD","LU0029864427.USD","LU1267930573.SGD","LU2237443382.USD","LU2236285917.USD","AZN","LU1829250122.USD","LU2456880835.USD","LU0058720904.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660072601","title":"阿斯利康(AZN.US)宣布终止其实验性药物volrustomig的临床试验，此前数据显示，该药物似乎无法在肺癌治疗方面","url":"https://stock-news.laohu8.com/highlight/detail?id=2660072601","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660072601?lang=zh_cn&edition=full","pubTime":"2026-08-17 14:48","pubTimestamp":1786949320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443549.SGD","LU0128525929.USD","IBBQ","LU2468319806.SGD","LU0432979614.USD","AZNH","MDTX","LU2237443895.HKD","LU0109394709.USD","IBBJ","LU2236285917.USD","LU1267930573.SGD","LU2237443622.USD","LU2417539215.USD","LU2089984988.USD","LU2462157665.USD","LU2237443382.USD","LU2456880835.USD","LU2237443978.SGD","PSYK","LU0320765992.SGD","LU2237443465.HKD","LU0058720904.USD","BMED","LU0310800379.SGD","LU0889565916.HKD","BK4568","BK4588","IE00B3T34201.USD","BK4585","BK4007","AZN","LU0708994859.HKD","LU0029864427.USD","LU0289739699.SGD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660074241","title":"阿斯利康宣布泰适卓在华上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660074241","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660074241?lang=zh_cn&edition=full","pubTime":"2026-08-17 14:24","pubTimestamp":1786947859,"startTime":"0","endTime":"0","summary":"阿斯利康宣布泰适卓在华上市","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843083635.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843083635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU2237443549.SGD","IE00B3T34201.USD","BK4007","IPOS","LU0128525929.USD","LU0058720904.USD","LU2089984988.USD","LU0109394709.USD","LU2236285917.USD","LU2237443622.USD","LU2468319806.SGD","LU2237443465.HKD","LU2237443895.HKD","AZNH","LU0289739699.SGD","LU1267930573.SGD","LU2456880835.USD","LU0432979614.USD","LU2417539215.USD","LU0310800379.SGD","AZN","LU2237443978.SGD","LU0889565916.HKD","BK4568","LU2462157665.USD","LU0320765992.SGD","BK4588","LU1829250122.USD","LU2237443382.USD","LU0029864427.USD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660107356","title":"阿斯利康宣布泰适卓正式在华上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660107356","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660107356?lang=zh_cn&edition=full","pubTime":"2026-08-17 14:19","pubTimestamp":1786947557,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0708994859.HKD","LU2236285917.USD","BK4007","LU2456880835.USD","LU0029864427.USD","LU1829250122.USD","LU0432979614.USD","LU1267930573.SGD","LU2237443382.USD","BK4588","LU0310800379.SGD","LU2089984988.USD","AZN","LU0109394709.USD","LU2462157665.USD","AZNH","LU0889565916.HKD","LU2237443622.USD","IPOS","LU2237443465.HKD","LU2468319806.SGD","LU2237443549.SGD","LU2237443895.HKD","LU0128525929.USD","BK4568","LU0289739699.SGD","BK4585","IE00B3T34201.USD","LU0320765992.SGD","LU2417539215.USD","LU2237443978.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165315","title":"市场消息：英国首相顾问就布里斯托尔并购案联系阿斯利康。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165315","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659165315?lang=zh_cn&edition=full","pubTime":"2026-08-13 23:13","pubTimestamp":1786633991,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU0310800379.SGD","LU0109394709.USD","LU0029864427.USD","IE00B3T34201.USD","LU2237443465.HKD","BK4568","LU0289739699.SGD","LU2237443382.USD","LU2237443622.USD","LU0128525929.USD","LU0320765992.SGD","LU0432979614.USD","LU2417539215.USD","AZNH","LU2237443978.SGD","LU1267930573.SGD","LU0708994859.HKD","LU2089984988.USD","BK4007","LU2236285917.USD","LU1829250122.USD","LU0058720904.USD","BK4588","AZN","LU0889565916.HKD","LU2462157665.USD","LU2237443895.HKD","LU2456880835.USD","LU2237443549.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659860121","title":"第一三共/阿斯利康(AZN.US)重磅ADC药物“德曲妥珠单抗”又一项新适应症在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2659860121","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659860121?lang=zh_cn&edition=full","pubTime":"2026-08-13 07:21","pubTimestamp":1786576889,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月12日，第一三共宣布，其与阿斯利康合作开发的重磅ADC药物“德曲妥珠单抗”一项新适应症获批上市，适应症为联合帕妥珠单抗用于不可切除或转移性HER2阳性成人乳腺癌患者的一线治疗。德曲妥珠单抗(DS-8201，商品名：优赫得®/Enhertu)是一款靶向HER2的ADC药物，由第一三共开发，并与阿斯利康在全球范围内共同开发和商业化。该药由HER2靶向抗体、可裂解四肽连接子和拓扑异构酶I抑制剂DXd(依喜替康衍生物)组成，DAR约为8。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","LU0029864427.USD","LU1829250122.USD","LU0310800379.SGD","NETL","LU2417539215.USD","LU2237443978.SGD","ADC","BK4585","LU2237443465.HKD","LU0708994859.HKD","LU0058720904.USD","IE00B3T34201.USD","LU2468319806.SGD","BK4080","LU0432979614.USD","BK4588","LU0320765992.SGD","LU2237443549.SGD","LU2462157665.USD","LU2456880835.USD","IPOS","LU2237443382.USD","LU2236285917.USD","LU2237443895.HKD","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","LU2089984988.USD","AZN","AZNH","LU0128525929.USD","LU1267930573.SGD","BK4007","LU2237443622.USD","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658769979","title":"石药创新(300765.SZ)：巨石生物已收到阿斯利康支付的3000万美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2658769979","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658769979?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:52","pubTimestamp":1786531939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药创新(300765.SZ)发布公告，2026年7月1日，公司控股子公司巨石生物与阿斯利康签署《合作、选择权及授权协议》，将与阿斯利康在新型小干扰核酸候选药物领域开展战略合作，开发新型肝外递送小干扰分子核酸候选药物。根据协议约定，巨石生物已于2026年8月12日收到阿斯利康支付的3000万美元首付款(实际到账金额须扣除银行手续费)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU2237443465.HKD","LU1829250122.USD","LU2237443895.HKD","LU1267930573.SGD","LU0109394709.USD","LU0889565916.HKD","BK4007","AZNH","LU0310800379.SGD","LU2417539215.USD","LU2237443978.SGD","BK4568","LU2237443382.USD","BK4585","LU2237443622.USD","BK0226","LU0708994859.HKD","LU0432979614.USD","LU0289739699.SGD","LU0320765992.SGD","LU2468319806.SGD","LU2462157665.USD","LU0058720904.USD","BK4588","LU2456880835.USD","IE00B3T34201.USD","LU2237443549.SGD","300765","LU0029864427.USD","AZN","LU2089984988.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658811976","title":"石药创新：控股子公司收到阿斯利康3000万美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2658811976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658811976?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:06","pubTimestamp":1786529180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443465.HKD","LU2237443895.HKD","LU0320765992.SGD","IE00B3T34201.USD","LU0310800379.SGD","LU2237443549.SGD","LU2456880835.USD","BK4007","LU0889565916.HKD","LU0128525929.USD","LU2468319806.SGD","BK4568","AZN","LU2237443622.USD","LU0432979614.USD","LU2237443382.USD","LU0029864427.USD","LU2236285917.USD","BK4588","BK4585","LU2237443978.SGD","LU1267930573.SGD","LU2089984988.USD","LU2462157665.USD","LU0708994859.HKD","LU0289739699.SGD","AZNH","LU0058720904.USD","LU2417539215.USD","LU1829250122.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657726255","title":"礼来上半年替尔泊肽大卖277亿美元；石药集团与阿斯利康成立合资公司丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2657726255","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657726255?lang=zh_cn&edition=full","pubTime":"2026-08-06 07:00","pubTimestamp":1785970805,"startTime":"0","endTime":"0","summary":"丨2026年8月6日星期四丨NO.1礼来：上半年替尔泊肽大卖277亿美元，中国区收入增长73%8月5日，礼来披露半年度业绩，公司上半年实现总营收427.73亿美元，同比增长49%。从地区分布来看，上半年美国市场收入265.32亿美元，同比增长37%，中国市场收入16.35亿美元，同比增长73%。上半年，礼来8款核心产品合计收入290.77亿美元，占总营收68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063832986566.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608063832986566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","LU2108987350.USD","LU0106261372.USD","LU2168563687.JPY","LU1979441026.SGD","CURE","SG9999014914.USD","LU1152091754.HKD","IE00BJJMRY28.SGD","LLYX","SG9999001176.USD","LU0198837287.USD","LU1770034418.SGD","IE00BJLML261.HKD","LU1813983027.USD","WDNA","LU1232071149.USD","LU0320765992.SGD","LU0964807845.USD","BK4599","RXL","BK4581","LU0672654240.SGD","LU0588546209.SGD","LU2750360641.GBP","LU0640476718.USD","LU0058720904.USD","LU0158827948.USD","LU1064131342.USD","BK1521","LU0466842654.USD","LU2168564149.EUR","LU1061106388.HKD","LLII","LU2168564495.EUR","MEDI","SGXZ81514606.USD","LU0823434740.USD","LU1057294990.SGD","LU0158827781.USD","LU0786609619.USD","06160","LU2237443549.SGD","LU0326950275.SGD","BK1583","BK4585","IE0009355771.USD","LU1366192091.USD","LU2756315664.SGD","LU0820561818.USD","LU2237438978.USD","BK4516","LU0122379950.USD","LU0238689110.USD","LU1035775433.USD","LU0266013472.USD","LU0316494557.USD","LU1093756168.USD","LU2361044865.SGD","IE00B3T34201.USD","LU0345770308.USD","HK0000165453.HKD","ELIS","LU0307460666.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU2756315318.SGD","CANC","IE00BZ08YT58.USD","LU2264538146.SGD","LU0067412154.USD","BK4007","ONC","LU0174119429.USD","LU2237443622.USD","LU2462157665.USD","IE00BFTCPJ56.SGD","SG9999014880.SGD","MHIP","BK4533","LU2106854487.HKD","LU1303224171.USD","LU0683600562.USD","LU2602419157.SGD","LU0006306889.USD","LU2417539215.USD","LU2361045086.USD","SG9999001176.SGD","SG9999013999.USD","LU1719994722.HKD","LU0029864427.USD","LU0471298694.HKD","LU0501845795.SGD","LU2089283258.USD","LU2746668461.USD","SG9999015978.USD","SG9999015952.SGD","IE0004445015.USD","KURE","LU0061475181.USD","LU1267930730.SGD","SGXZ31699556.SGD","LU2112291526.USD","LU2360106947.USD","LU1868837300.USD","LU0320765059.SGD","LU1720051108.HKD","VHT","IE00B031HY20.USD","FTXH","LU1988902786.USD","IE00BKDWB100.SGD","BK1161","LU2237443895.HKD","IE00BWXC8680.SGD","BK4588","SG9999017495.SGD","GDOC","LU0225283273.USD","IE00B7KXQ091.USD","LU2028103732.USD","LU2211815571.USD","IE00BJT1NW94.SGD","LU1291159041.SGD","01093","LU0882574055.USD","688331","LU1226287792.SGD","LU0889565916.HKD","LU0203201768.USD","LU2491049909.HKD","LU2328871848.SGD","LU0943347566.SGD","IE0001KFT4U8.USD","IE00B2B36J28.USD","LU2213496289.HKD","SGXZ99366536.SGD","LU1868836914.USD","LU1951186391.HKD","LU1868836757.USD","LU2237443978.SGD","LU0432979614.USD","LU2746668974.SGD","GB00BDT5M118.USD","LU0880133367.SGD","IE00BJJMRZ35.SGD","LU2491050071.SGD","LU1328277881.USD","BK4568","LU0096364046.USD","LU1623119135.USD","LU0353189763.USD","BK1574","IE00BK4W5M84.HKD","FHLC","LU1974910355.USD","BK4534","LLY","IE00B1XK9C88.USD","LU2168564222.USD","LU1267930573.SGD","IE00B4JS1V06.HKD","IE00BFSS8Q28.SGD","LU0109394709.USD","LU2265009873.SGD","LU0456855351.SGD","LU2896262040.SGD","AZNH","IYH","LU0256863902.USD","IE00B775H168.HKD","IE00BZ08YR35.GBP","LU1917777945.USD","IE0005OL40V9.USD","SG9999015986.USD","LU0140636845.USD","LU0385154629.USD","LU0820562030.AUD","LU1960683339.HKD","IHE","THNR","SG9999014906.USD","ILDR","LU2039709279.SGD","LU0823434583.USD","LU2357305700.SGD","IE00B543WZ88.USD","LU2468319806.SGD","BK1500","OZEM","IE00B5MMRT66.SGD","LU2111349929.HKD","SGXZ51526630.SGD","HRTS","IE0008368742.USD","LU1804176565.USD","BK1588","PJP","LLYZ","LU2552382132.HKD","LU2552382215.SGD","LU1280957306.USD","IE00BN29S564.USD","LU1807302812.USD","LU0210536198.USD","LU1720051017.SGD","LU0787776722.HKD","AGNG","LU0072913022.USD","IE0002141913.USD","LU0094547139.USD","09995","LU0097036916.USD","SG9999014898.SGD","LU0689472784.USD","LU1989771016.USD","PPH","LU1069344957.HKD","LU2023250330.USD","AZN","LU2361044949.HKD","IE00B1BXHZ80.USD","JDOC","LU1145028129.USD","SG9999018857.SGD","LU2023250504.SGD","LU1127390331.HKD","LU0823416689.USD","LU0128525929.USD","IE00BKPKM429.USD","LU0323591593.USD","TRUH","LU0256863811.USD","LU1814569148.SGD","LU0109391861.USD","LU0354030511.USD","LU1969619763.USD","LU2462591350.SGD","LU0882574139.USD","LU1868837136.USD","IE00BZ08YS42.EUR","LU2236285917.USD","LU2491050154.USD","LU2087625088.SGD","IE00BK4W5L77.USD","LU1251922891.USD","LU1548497426.USD","SG9999018865.SGD","LU0354030438.USD","SG9999004220.SGD","LU1993786604.SGD","LU0315179316.USD","BK1191","LU1868836591.USD","TMED","LU2237443465.HKD","LU0114720955.EUR","LU0203202063.USD","LU0314109678.HKD","LU0708994859.HKD","LU0471298777.SGD","LU1551013342.USD","LU1712237335.SGD","LU2168564065.EUR","MEDX","SG9999015945.SGD","IXJ","LU2456880835.USD","SGXZ57979304.SGD","LU0708995401.HKD","LU2063271972.USD","IE00BFSS7M15.SGD","LU2552382058.USD","LU2471134796.USD","LU1629891620.HKD","LU1226287875.USD","LU0353189680.USD","688235","LU0345770993.USD","LU0234572021.USD","LU2471134879.HKD","LU2750360997.AUD","LU0133085943.USD","LU1323610961.USD","LU1551013425.SGD","LU1008478684.HKD","LU1226287529.USD","LU0079474960.USD","LU2461242641.AUD","LU0289739699.SGD","LU0417517546.SGD","LU2237443382.USD","IE0008369823.USD","LU1023059063.AUD","IE0004445239.USD","LU2471134952.CNY","XLV","LU2023251221.USD","LU1983299246.USD","LU1226288253.USD","LU1226288170.HKD","LU2471134523.USD","IE00BJJMRX11.SGD","LU0310800379.SGD","LU0820561909.HKD","LU2089984988.USD","LU1093756325.SGD","LU1152091168.USD","LU2089284900.SGD","BK1515","ELIL","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540291","title":"美股异动｜阿斯利康反弹涨超4%，消息人士否认与施贵宝合并传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540291","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657540291?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:46","pubTimestamp":1785937567,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756325.SGD","LU2242652126.USD","LU1868837136.USD","LU1829250122.USD","LU1868836591.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","BK4581","LU1585245621.USD","LU0058720904.USD","LU2237443622.USD","IE00BFXG1179.USD","LU0114720955.EUR","LU0267386448.USD","LU0882574055.USD","LU0889565916.HKD","IHE","LU1718418525.SGD","LU2462157665.USD","AZNH","LU0289739699.SGD","BK4532","LU0096364046.USD","LU0320765992.SGD","IE00BSNM7G36.USD","LU0237698245.USD","LU0306806265.USD","LU1291159041.SGD","LU1670711040.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","LU1989771016.USD","BK4559","LU2236285917.USD","BK4568","BMY","AZN","FTXH","LU1267930573.SGD","LU1430594728.SGD","LU0456855351.SGD","BK4585","IE0009355771.USD","LU0985481810.HKD","LU1983299246.USD","LU2242646821.SGD","LU1093756168.USD","LU0029864427.USD","LU1868836914.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154589729","title":"异动解读｜阿斯利康盘中上涨4.97%，合并施贵宝传闻遭权威否认后超跌修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1154589729","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154589729?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:38","pubTimestamp":1785937112,"startTime":"0","endTime":"0","summary":"8月5日，阿斯利康盘中上涨4.97%，报163.17美元/股，成交额3.48亿美元。消息面上，多位知情资深消息人士明确表示，阿斯利康与百时美施贵宝之间\"从始至终从未有过交易谈判\"，此前合并传闻被正式否认。此外，石药集团宣布与阿斯利康签署合资合同并收到1000万美元里程碑付款，业务拓展信号积极。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"阿斯利康盘中上涨4.97%，合并施贵宝传闻遭权威否认后超跌修复","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547492","title":"石药集团：收到阿斯利康就战略研发合作协议项下的1000万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547492","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657547492?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:12","pubTimestamp":1785935534,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2468319806.SGD","BK4585","LU0029864427.USD","AZNH","IE00B3T34201.USD","LU2237443622.USD","LU0128525929.USD","LU2456880835.USD","LU0058720904.USD","AZN","LU2237443382.USD","LU2417539215.USD","LU0889565916.HKD","LU2237443978.SGD","LU0432979614.USD","LU1829250122.USD","LU2237443465.HKD","LU2089984988.USD","LU2462157665.USD","LU2237443549.SGD","BK4588","LU1267930573.SGD","LU0289739699.SGD","LU0109394709.USD","LU2236285917.USD","LU2237443895.HKD","BK4007","BK4568","LU0708994859.HKD","LU0310800379.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657542821","title":"阿斯利康股价大涨，消息称目前未与百时美施贵宝进行并购谈判后，该股日内涨幅现已达到3.5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657542821","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657542821?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:32","pubTimestamp":1785933172,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0058720904.USD","LU0306807586.USD","LU1829250122.USD","LU2596442595.SGD","LU2237443978.SGD","LU0128525929.USD","LU0114720955.EUR","LU1868836591.USD","LU0061475181.USD","IE0002141913.USD","LU0889565916.HKD","BMY","CALF","IE00B3T34201.USD","LU1430594728.SGD","LU2242652126.USD","LU1670710661.SGD","LU0321505439.SGD","LU0267386448.USD","LU0029864427.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU1261432733.SGD","LU0882574055.USD","BK4007","AZNH","AZN","LU1868837136.USD","LU2468319806.SGD","BK4585","LU2242646821.SGD","LU1093756168.USD","LU2456880835.USD","XMMO","FTXH","IHE","MYLD","IE0009355771.USD","LU0310800379.SGD","LU0868494617.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU0225284248.USD","IE00B2B36J28.USD","BK4532","LU2237443382.USD","KCE","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111805047","title":"市场消息：阿斯利康与施贵宝之间没有就潜在交易进行任何讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=1111805047","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111805047?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:09","pubTimestamp":1785931786,"startTime":"0","endTime":"0","summary":"8月5日，阿斯利康盘前涨超5%、施贵宝跌近3%；消息人士表示双方之间没有就潜在交易进行任何讨论。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"市场消息：阿斯利康与施贵宝之间没有就潜在交易进行任何讨论","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189670438","title":"异动解读｜阿斯利康盘前上涨4.77%，合并施贵宝传闻遭多方泼冷水后股价修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1189670438","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189670438?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:05","pubTimestamp":1785931506,"startTime":"0","endTime":"0","summary":"8月5日，阿斯利康盘前上涨4.77%，报163.08美元/股，成交额2740.35万美元。消息面上，此前阿斯利康因洽谈合并百时美施贵宝的传闻股价大跌逾9%，但随后多家投行对该交易可行性表示质疑。BMO资本研报指出，两家公司均无足够财务实力直接收购对方，阿斯利康约可筹370亿美元，远低于4000亿美元合并所需资金。此外，阿斯利康与石药集团就成立合资公司签署合资合同，业务拓展信号积极。市场对巨型并购交易落地预期降温，前期超跌股价迎来修复。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"阿斯利康盘前上涨4.77%，合并施贵宝传闻遭多方泼冷水后股价修复","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541044","title":"消息人士表示，阿斯利康(AZN.US)与施贵宝(BMY.US)之间没有就潜在交易进行任何讨论。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541044","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657541044?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:04","pubTimestamp":1785931448,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BSNM7G36.USD","LU2468319806.SGD","BK4585","IE00B2B36J28.USD","LU0029864427.USD","AZNH","LU0096364046.USD","LU1868836757.USD","LU0128525929.USD","LU2456880835.USD","LU0058720904.USD","AZN","LU0237698245.USD","LU2242646821.SGD","LU2133065610.SGD","LU0889565916.HKD","LU1670710661.SGD","LU2237443978.SGD","IE00BJT1NW94.SGD","LU2360032135.SGD","LU0882574055.USD","LU0432979614.USD","BMY","LU1670711040.USD","LU1989771016.USD","LU1829250122.USD","LU1291159041.SGD","LU2237443465.HKD","FTXH","IE0009355771.USD","LU2089984988.USD","LU2462157665.USD","LU2237443549.SGD","LU0225771236.USD","LU2125154778.USD","LU1571399168.USD","LU1868837136.USD","LU0114720955.EUR","LU1032466523.USD","LU0306807586.USD","IE00BFXG1179.USD","LU1868836591.USD","LU0985481810.HKD","BK4007","LU2237443895.HKD","IE00BFTCPJ56.SGD","LU1868837300.USD","IHE","LU0708994859.HKD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657027541","title":"一位知情资深消息人士称，阿斯利康与百时美施贵宝“从始至终从未有过交易谈判”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657027541","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657027541?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:03","pubTimestamp":1785931439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1571399168.USD","LU1868836914.USD","LU2456880835.USD","IE00B3T34201.USD","BMY","IE00B2B36J28.USD","LU1829250122.USD","LU1267930573.SGD","LU0456855351.SGD","LU1261432733.SGD","LU1032466523.USD","LU1291159041.SGD","BK4534","IE00BJJMRZ35.SGD","AZNH","LU0289739699.SGD","BK4581","LU1093756325.SGD","LU2089984988.USD","LU1323610961.USD","LU1883839398.USD","LU0708994859.HKD","BK4588","IE00BFTCPJ56.SGD","IHE","LU1093756168.USD","LU2462157665.USD","LU2596442595.SGD","BK4568","LU1430594728.SGD","LU0128525929.USD","LU2360032135.SGD","LU1670710661.SGD","LU0868494617.USD","LU0985481810.HKD","AZN","BK4559","FTXH","LU2237443382.USD","LU2133065610.SGD","LU2237443978.SGD","LU0029864427.USD","LU1868836591.USD","LU0321505868.SGD","LU0225284248.USD","LU0889565916.HKD","LU0310800379.SGD","LU0267386448.USD","LU0320765992.SGD","LU1670711040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astrazeneca.com","stockEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":-0.0708},{"period":"3month","weight":-0.1384},{"period":"6month","weight":-0.2389},{"period":"1year","weight":-0.0031},{"period":"ytd","weight":-0.1491}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"阿斯利康股份有限公司于1992年6月17日根据1985年《公司法》在英格兰和威尔士注册成立。该公司是在1993年将Imperial化学工业公司的制药、农化和特种化学品业务分拆时成立的。1999年，公司出售了特种化学品业务。同样在1999年，该公司与瑞典Astra公司合并。2000年，该公司将农化业务分拆，并将其与诺华公司的同类业务合并，成立了一家新的公司Syngenta AG。2007年，集团收购了位于美国的生物制剂和疫苗企业MedImmune。2021年，集团收购了位于美国的罕见病企业Alexion。","yearOnYearQuotes":[{"month":1,"riseRate":0.515152,"avgChangeRate":0.001662},{"month":2,"riseRate":0.424242,"avgChangeRate":-0.012868},{"month":3,"riseRate":0.545455,"avgChangeRate":0.025511},{"month":4,"riseRate":0.636364,"avgChangeRate":0.028791},{"month":5,"riseRate":0.515152,"avgChangeRate":0.008212},{"month":6,"riseRate":0.470588,"avgChangeRate":0.018421},{"month":7,"riseRate":0.588235,"avgChangeRate":-0.005538},{"month":8,"riseRate":0.470588,"avgChangeRate":0.002361},{"month":9,"riseRate":0.545455,"avgChangeRate":0.001232},{"month":10,"riseRate":0.545455,"avgChangeRate":0.015301},{"month":11,"riseRate":0.515152,"avgChangeRate":0.003764},{"month":12,"riseRate":0.545455,"avgChangeRate":0.007464}],"exchange":"NYSE","name":"阿斯利康","nameEN":"AstraZeneca PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿斯利康(AZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿斯利康,AZN,阿斯利康股票,阿斯利康股票老虎,阿斯利康股票老虎国际,阿斯利康行情,阿斯利康股票行情,阿斯利康股价,阿斯利康股市,阿斯利康股票价格,阿斯利康股票交易,阿斯利康股票购买,阿斯利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿斯利康(AZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}